St LouisM, HolmesKK. Conceptual framework for STD/HIV prevention and control. HolmesKK, SparlingF, MardhP-Fet al.Sexually transmitted diseases, 3rd. New York: McGraw-Hill, 1999; 1239–1253.
2.
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2007; 147:128–134.
3.
MaciosekMV, CoffieldAB, EdwardsNMet al.Priorities among effective clinical preventive services: Results of a systematic review and analysis. Am J Prev Med, 2006; 31:52–61.
4.
Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans—United States, 2000–2007. MMWR, 2009; 58:362–365.
5.
ParkIU, AmeyA, CreeganL, BarandasA, BauerHM. Retesting for repeat chlamydial infection: Family planning provider knowledge, attitudes, and practices. J Womens Health, 2010; 19:1139–1144.
6.
BauerHM, WohlfeilerD, KlausnerJDet al.California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis, 2008; 35:314–319.
7.
AralSO, BlanchardJ, DelisleS, FentonK. The “program science” development initiative: Proposal for a core group formation meeting. Presented at the National STD Prevention Conference, Chicago, IL, 2007.
8.
MalotteCK, LedskyR, HogbenMet al.Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis, 2004; 31:637–642.
9.
SwendemanD, Rotheram-BorusMJ. Innovation in sexually transmitted disease and HIV prevention: Internet and mobile phone delivery vehicles for global diffusion. Curr Opin Psychiatry, 2010; 23:1–6.
10.
GaydosCA, DwyerK, BarnesMet al.Internet-based screening for Chlamydia trachomatis to reach nonclinic populations with mailed self-administered vaginal swabs. Sex Transm Dis, 2006; 33:451–457.
